- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mechanism of coordinated access to orphan drugs ; volume:7 ; number:2 ; day:22 ; month:11 ; year:2012 ; pages:1-2 ; date:11.2012
Orphanet journal of rare diseases ; 7, Heft 2 (22.11.2012), 1-2, 11.2012
- Creator
-
DeRidder, R.
- Contributor
-
Adriaens, C.
Kleinermans, D.
Mortier, M.
Quanten, A.
Arickx, F.
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-7-S2-A24
- URN
-
urn:nbn:de:1111-2016050121996
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- DeRidder, R.
- Adriaens, C.
- Kleinermans, D.
- Mortier, M.
- Quanten, A.
- Arickx, F.
- SpringerLink (Online service)
Other Objects (12)
Patient access to orphan drugs in France
Analysis of patient access to orphan drugs in Turkey
Markenführung Orphan Drugs
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Market access of orphan drugs and the role of multi-criteria decision making
Seltene Helden : Orphan Drugs in Deutschland
Comparing access to orphan medicinal products in Europe
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Rare diseases and orphan drugs: Latvian story
Patient access to orphan drugs in France
Analysis of patient access to orphan drugs in Turkey
Markenführung Orphan Drugs
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Market access of orphan drugs and the role of multi-criteria decision making
Seltene Helden : Orphan Drugs in Deutschland
Comparing access to orphan medicinal products in Europe
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Rare diseases and orphan drugs: Latvian story
Patient access to orphan drugs in France
Analysis of patient access to orphan drugs in Turkey
Markenführung Orphan Drugs
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Market access of orphan drugs and the role of multi-criteria decision making
Seltene Helden : Orphan Drugs in Deutschland
Comparing access to orphan medicinal products in Europe
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders